TCR² Therapeutics Inc. Rings the Closing Bell

Date & Time Oct 11, 2019 3:45pm - 4:15pm
Location Nasdaq MarketSite, 4 Times Square New York


TCR² Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company, visited the Nasdaq MarketSite in Times Square.

In honor of the occasion, Garry Menzel, Ph.D., MBA, President & CEO, rang the Closing Bell.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now